Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL

tel.archives.ouvertes.fr
from tel.archives.ouvertes.fr More from this publisher
27.06.2013 Views

tel-00827710, version 1 - 29 May 2013 114

tel-00827710, version 1 - 29 May 2013 In instances where microbial associated molecular patterns are absent (e.g., cell-associated antigen), it is common practice to formulate the vaccine with an adjuvant. While adjuvants have been shown to be useful for enhancing the response to antigen, it has also been observed that DC maturation prior to immunization can have the opposite effect – the inhibition of subsequent T cell priming (Wilson et al., 2006). Following from our results indicating delayed cross-presentation after i.d. immunization (Figure 32), we predicted that the optimal timing of adjuvant delivery will depend on the route of immunization. I. THE OPTIMAL TIMING FOR ADJUVANT DELIVERY IS DEPENDENT ON THE ROUTE OF IMMUNIZATION Our prediction was that the optimal timing for adjuvant delivery may be earlier for i.v. immunization as compared to i.d. immunization, due to the different kinetic of cross- presentation observed in Figure 32. To test this, mice were again immunized with K bm1 mOva splenocytes i.d. or i.v. Poly I:C was used as an adjuvant and administered at different time points relative to immunization with antigen. The absolute number of antigen-specific T cells was determined at the respective time of peak response (day 7 for i.v. and day 9 for i.d. immunization). When poly I:C was injected one day prior, or the day of i.v. immunization with the K bm1 mOva cells, T cell priming was greatly reduced (Figure 37A). Strikingly, injection of poly I:C one day after i.v. immunization enhanced T cell priming. For the i.d. route, poly I:C injection one day prior to, the day of, or even one day after immunization, resulted in the inhibition of T cell priming (Figure 37B). It was necessary to wait until three days post-immunization to inject poly I:C in order to observe an enhancement of T cell priming (Figure 37B). Following from the results presented in Figure 32, we suggest that antigen capture has to occur prior to adjuvant detection by DCs and that one day of antigen capture is sufficient to permit T cell priming after i.v. immunization, but that additional time is required for antigen capture after i.d. immunization. This hypothesis could explain why delayed adjuvant delivery is optimal for i.d. immunization. Page 115 of 256

tel-00827710, version 1 - 29 May 2013<br />

In instances where microbial associated molecular patterns are absent (e.g., cell-associated<br />

antigen), it is common practice to formulate the vaccine with an adjuvant. While adjuvants<br />

have been shown to be useful for enhancing the response to antigen, it has also been observed<br />

that DC maturation prior to immunization can have the opposite effect – the inhibition of<br />

subsequent T cell priming (Wilson <strong>et</strong> al., 2006). Following from our results indicating<br />

<strong>de</strong>layed cross-presentation after i.d. immunization (Figure 32), we predicted that the optimal<br />

timing of adjuvant <strong>de</strong>livery will <strong>de</strong>pend on the route of immunization.<br />

I. THE OPTIMAL TIMING FOR ADJUVANT DELIVERY IS<br />

DEPENDENT ON THE ROUTE OF IMMUNIZATION<br />

Our prediction was that the optimal timing for adjuvant <strong>de</strong>livery may be earlier for i.v.<br />

immunization as compared to i.d. immunization, due to the different kin<strong>et</strong>ic of cross-<br />

presentation observed in Figure 32. To test this, mice were again immunized with K bm1 mOva<br />

splenocytes i.d. or i.v. Poly I:C was used as an adjuvant and administered at different time<br />

points relative to immunization with antigen. The absolute number of antigen-specific T cells<br />

was d<strong>et</strong>ermined at the respective time of peak response (day 7 for i.v. and day 9 for i.d.<br />

immunization). When poly I:C was injected one day prior, or the day of i.v. immunization<br />

with the K bm1 mOva cells, T cell priming was greatly reduced (Figure 37A). Strikingly,<br />

injection of poly I:C one day after i.v. immunization enhanced T cell priming. For the i.d.<br />

route, poly I:C injection one day prior to, the day of, or even one day after immunization,<br />

resulted in the inhibition of T cell priming (Figure 37B). It was necessary to wait until three<br />

days post-immunization to inject poly I:C in or<strong>de</strong>r to observe an enhancement of T cell<br />

priming (Figure 37B). Following from the results presented in Figure 32, we suggest that<br />

antigen capture has to occur prior to adjuvant d<strong>et</strong>ection by DCs and that one day of antigen<br />

capture is sufficient to permit T cell priming after i.v. immunization, but that additional time<br />

is required for antigen capture after i.d. immunization. This hypothesis could explain why<br />

<strong>de</strong>layed adjuvant <strong>de</strong>livery is optimal for i.d. immunization.<br />

Page 115 of 256

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!